Diagnostic & Scientific Liaison - Oncology (Denmark)

About the role

AstraZeneca's Nordic Marketing Company is looking for a Diagnostic and Scientific Liaison for oncology diagnostics in Denmark. You will act as the in-country scientific expert, turning strategy into practical testing solutions that help identify the right patients faster and give clinicians the evidence they need. The company has offices in Copenhagen, Stockholm, Oslo and Espoo.

Key responsibilities

• Assess the country's diagnostic landscape, patient pathways and laboratory capacity, and turn this into practical testing plans aligned with Nordic and global priorities.
• Build trusted partnerships with laboratory leaders, pathologists, molecular specialists and oncologists through education and tailored technical communication.
• Help scientific experts understand the science behind current and future brands and the need to diagnose the right target segment.
• Identify barriers to timely testing and co-create compliant solutions that improve quality, timeliness and equity.
• Provide diagnostic intelligence to support launches, validation, real-world evidence and research.
• Lead cross-functional projects with country, Nordic and global teams, and uphold scientific, ethical, privacy, safety, quality and compliance standards.

Required profile

• Degree in life sciences, biomedical science, medicine, pharmacy or a related field, with about 3-5 years' experience in diagnostics, biomarker testing, clinical laboratories or healthcare.
• Fluency in English and the relevant local Nordic language, with regular travel in-country and across the Nordics.
• Valid driver's licence, as this is a field-based role.
• Desirable: advanced degree or experience in oncology diagnostics, companion diagnostics or biomarker testing (IHC, NGS, PCR); background in pharma, biotech, diagnostics or clinical laboratories; understanding of local diagnostic regulations and quality assurance; experience with launches, validation and real-world evidence; experience in Nordic projects.

Applications are submitted online in English by 15 November 2026 and reviewed continuously.